Y Intercept Hong Kong Ltd Acquires 311,813 Shares of Core Scientific, Inc. $CORZ

Y Intercept Hong Kong Ltd raised its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 87.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 668,435 shares of the company’s stock after acquiring an additional 311,813 shares during the period. Y Intercept Hong Kong Ltd owned approximately 0.22% of Core Scientific worth $11,992,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. HHM Wealth Advisors LLC grew its stake in shares of Core Scientific by 96.5% during the second quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock worth $33,000 after purchasing an additional 946 shares during the period. Osaic Holdings Inc. boosted its holdings in Core Scientific by 112.1% during the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock worth $34,000 after buying an additional 1,066 shares during the last quarter. Advisors Asset Management Inc. grew its position in shares of Core Scientific by 68.3% during the 2nd quarter. Advisors Asset Management Inc. now owns 2,690 shares of the company’s stock worth $46,000 after buying an additional 1,092 shares during the period. Main Management ETF Advisors LLC increased its stake in shares of Core Scientific by 1.6% in the 2nd quarter. Main Management ETF Advisors LLC now owns 82,075 shares of the company’s stock valued at $1,401,000 after acquiring an additional 1,332 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its stake in shares of Core Scientific by 61.9% in the 2nd quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock valued at $67,000 after acquiring an additional 1,507 shares during the last quarter.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price objective on the stock in a research note on Thursday, December 18th. Macquarie raised shares of Core Scientific from a “hold” rating to an “outperform” rating and lifted their price target for the stock from $18.00 to $34.00 in a research report on Friday, October 31st. UBS Group set a $30.00 price target on shares of Core Scientific in a report on Wednesday, October 22nd. Roth Mkm restated a “buy” rating on shares of Core Scientific in a research report on Friday, October 31st. Finally, Zacks Research upgraded Core Scientific from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 13th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Core Scientific currently has an average rating of “Moderate Buy” and a consensus price target of $23.53.

Insider Buying and Selling at Core Scientific

In other news, Director Eric Stanton Weiss acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 4th. The stock was acquired at an average cost of $21.50 per share, for a total transaction of $107,500.00. Following the completion of the acquisition, the director owned 226,687 shares in the company, valued at $4,873,770.50. This represents a 2.26% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.40% of the stock is owned by corporate insiders.

Core Scientific Stock Up 3.9%

Shares of NASDAQ:CORZ opened at $18.79 on Friday. The firm has a market cap of $5.83 billion, a price-to-earnings ratio of 125.28 and a beta of 6.87. Core Scientific, Inc. has a 12 month low of $6.20 and a 12 month high of $23.63. The company’s fifty day simple moving average is $16.37 and its 200 day simple moving average is $16.18.

Core Scientific (NASDAQ:CORZ) last released its earnings results on Friday, October 24th. The company reported ($0.46) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.85) by $0.39. The firm had revenue of $81.10 million for the quarter, compared to the consensus estimate of $107.18 million. Research analysts expect that Core Scientific, Inc. will post 0.52 earnings per share for the current fiscal year.

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.